CRMD(CorMedix Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2020-12-31 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $239.23K | $190.94K | $65.41K | $43.47M | $311.71M |
| 毛利润 | $34.38K | $42.00K | $61.67K | $40.28M | $275.75M |
| 营业利润 | −$27.22M | −$29.44M | −$30.62M | −$22.36M | $150.14M |
| 净利润 | −$22.03M | −$28.21M | −$29.70M | −$17.93M | $163.06M |
| 经营现金流 | −$21.97M | −$21.16M | −$24.36M | −$50.62M | $175.05M |
| 自由现金流 | −$22.08M | −$22.58M | −$24.58M | −$50.73M | $172.79M |
| 摊薄每股收益 | $-0.77 | $-0.75 | $-0.74 | $-0.30 | $2.04 |